期刊文献+

VEGF在鼻咽癌中的表达及其与预后关系 被引量:4

The Expression of Vascular Endothelial Growth Factor in Nasopharyngeal Carcinoma and Its Relationship with Prognosis
下载PDF
导出
摘要 [目的]研究血管内皮生长因子(VEGF)在鼻咽癌中的表达与鼻咽癌患者预后的关系。[方法]通过组织芯片技术与免疫组织化学方法回顾性研究1990 ̄2002年期间200例有临床随访资料的鼻咽癌组织中VEGF蛋白的表达情况,应用卡方检验分析鼻咽癌组织VEGF蛋白表达与临床病理参数之间的关系,并通过生存分析计算鼻咽癌组织内VEGF不同表达组的总生存率。[结果]VEGF在鼻咽癌组织中阳性表达主要位于肿瘤细胞胞浆内。VEGF在鼻咽癌组织中的表达与鼻咽癌患者的TNM分期、复发及远处转移呈正相关(P<0.05)。VEGF表达阳性及阴性患者5年生存率分别为40.11%和67.75%,两组生存率存在显著性差异(P<0.01)。[结论]VEGF的表达与鼻咽癌患者TNM分期、复发及远处转移呈明显正相关,其高表达提示预后不良。 [Purpose] To investigate the expression of vascular endothelial growth factor(VEGF) in nasopharyngeal carcinoma (NPC) and its relationship with prognosis of NPC. [Methods] The expression of VEGF in 200 cases of NPC with followed-up data from 1990 to 2002 was analyzed by high-throughput tissue microarray technology and immunohistoehemistry. The relationship between expression of VEGF and clinical characteristics of the patients with NPC was analyzed with chi-square test. The survival rates between different tissues VEGF expressions in NPC were compared. [Results] The positive expression of VEGF in NPC was observed mainly in cytoplasm of tumor cells. And the expression of VEGF in NPC tissue positively correlated with the TNM stage, recurrence and distant metastasis(P〈0.05). The 5 year overall survival rates of patients with positive and negative expression of VEGF were 40.11% and 67.75% respectively. The survival rates of different groups were significantly different by log rank test (P〈0.01). [Conclusion] The expression of VEGF in NPC tissue positively correlated with the TNM stage, recurrence and distant metastasis. High expression of VEGF in patients with NPC predicts poor prognosis.
出处 《中国肿瘤》 CAS 2006年第7期466-469,共4页 China Cancer
基金 "十五"国家重大科技专项分题(2002BA711A03) 广东省科技计划项目(2003A3080202)
关键词 鼻咽肿瘤 组织芯片 血管内皮生长因子 预后 nasopharyngeal neoplasms tissue microarray vascular endothelial growth factor prognosis
  • 相关文献

参考文献4

二级参考文献44

  • 1刘泰福,徐国镇.全国鼻咽癌会议纪要[J].中华放射肿瘤学杂志,1992,0(4):5-10. 被引量:132
  • 2闵华庆 李树玲.鼻咽癌.头颈肿瘤学[M].天津:天津科学技术出版社,1993.536-604.
  • 3Niitsu N, Iijima K. High serum soluble CD44 is correlated with a poor outcome of aggressive non Hodgkin s lymphoma [J]. Leuk Res, 2002, 26(3):241- 248.
  • 4Molica S, Vitelli G, Levato D,et al. Elevated serum levels of soluble CD44 can identify a subgroup of patients with early B cell chronic lymphocyte leukemia who are at high risk of disease progression [J]. Cancer, 2001,92(4):713- 719.
  • 5Guo YJ, Liu G, Wang X, et al. Potential use of soluble CD44 in serum as indictor of tumor burden and metastasis in patients with gastric or colon cancer [J]. Cancer Res, 1994, 54:422- 426.
  • 6Masson D, Denis MG, Denis M, et al. Soluble CD44: Quantification and molecular repartition in plasma of patients with colorectal cancer [J]. Br J Cancer,1999 , 80(12):1995- 2000.
  • 7Kuropkat C, Plehn S, Herz U,et al. Tumor marker potential of serum matrix metalloproteinase in patients with head and neck cancer [J]. Anticancer Res, 2002, 22(4):2221- 2227.
  • 8Gojhi K, Fujimoto N, Komiyama T, et al. Elevation of serum levels of matrix metalloproteinase 2 and 3 as new predictors in patients with urothelial carcinoma [J]. Cancer,1996,78:2379- 2387.
  • 9Qian CN, Zhang CQ, Guo X, et al. Elevation of serum vascular endothelial growth factor in male patients with metastatic nasopharyngeal carcinoma [J]. Cancer, 2000, 88(2):255- 261.
  • 10Poon RT, Fan ST, Wong J. Clinical implications of circulating angiogenic factors in cancer patients [J]. J Clin Oncol, 2001,19(4):1207- 1225.

共引文献40

同被引文献45

引证文献4

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部